-+ 0.00%
-+ 0.00%
-+ 0.00%

Capbio (300639.SZ) announced first-half results, turning losses into profits of 31.2621 million yuan

Zhitongcaijing·08/14/2026 08:09:09
Listen to the news

According to the Zhitong Finance App, Capbio (300639.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 300 million yuan, a year-on-year decrease of 4.74%. Achieved net profit of 31.2621 million yuan attributable to shareholders of listed companies. Achieve net profit of 12.134,400 yuan, which is attributable to shareholders of listed companies after deducting non-recurring profit and loss. Basic earnings per share were $0.0484.

The business situation has improved dramatically. The specific reasons are as follows: 1. In terms of molecular diagnostic products, due to the inclusion of HPV-DNA testing series products and intense competition in the IVD industry, product sales prices have declined, and revenue from molecular diagnostic products has declined. 2. In terms of medical testing services, due to the large fixed costs and labor expenses of the laboratory, related revenue did not cover the costs, resulting in operating losses in the medical testing business. However, the company continued to take measures to reduce costs and increase efficiency and achieved certain results. The impact of impairment accruals was excluded during the reporting period, and operating losses narrowed compared to the same period last year. 3. In terms of medical diagnosis and treatment services, the initial revenue scale of Chaozhou Kaipkang Hospital's operation did not cover operating costs such as depreciation of fixed assets and labor costs. However, during the reporting period, revenue increased 102.69% over the same period of the previous year, and operating losses narrowed compared to the same period of the previous year. 4. The company continues to strengthen the control of accounts receivable settlement, and has taken more measures to promote the collection of overdue payments, successfully recover some accounts receivable that have already been prepared for bad debts in the previous period, and transfer back to bad debt preparations accordingly.